1.. Introduction {#S1}
================

Adult mature blood cells are constantly being generated from hematopoietic stem cells (HSCs), moving through several lineage-committed progenitor stages in a highly tuned process, called hematopoiesis ([@R23]). HSCs must limit mitochondrial respiration to remain in a quiescent state ([@R31]; [@R34]; [@R36]), while the metabolic profiles and mitochondrial functions of cells drastically change in the various stages of differentiation ([@R31]; [@R14]; [@R17]).

Mitochondria are dynamic and complex organelles that play a critical role in many processes and functions as the major metabolic and bioenergetics organelles for the cell. In addition to apoptosis and calcium signaling, mitochondria regulate the electron transport chain (ETC) and ATP generation by oxidative phosphorylation (OxPHOS), as well as reactive oxygen species (ROS) and tricarboxylic acid (TCA) cycle activity, and therefore contribute greatly to hematopoietic homeostasis ([@R14]; [@R6]; [@R13]; [@R9]).

HSCs predominantly rely on glycolysis, but during differentiation a rapid switch to mitochondrial OxPHOS occurs, and this metabolic program is thought to be essential to driving their fate decisions regarding self-renewal or commitment, in addition to the adaptations required for specific microenvironments in the bone marrow niche ([@R28]). The role of mitochondria in HSC fate determination is not limited to this metabolic adjustment, but also involves the alteration of mitochondrial features and properties ([@R24]; [@R19]). It has been widely reported that HSCs exhibited an immature mitochondrial network with globular and primitive cristae and displayed a low metabolic profile supported by low mitochondrial ROS levels, mass and mitochondrial membrane potential (ΔΨ~mt~) ([@R24]; [@R33]). Interestingly, however, these claims have recently come under renewed scrutiny. In particular, it was recently demonstrated that the dyes commonly used for the study of mitochondrial mass in bone marrow populations were affected by mitochondrial physiology, potentially biasing experimental conclusions ([@R7]; [@R3]). Indeed, multiple studies using ΔΨ~mt~-independent methods soon confirmed that mitochondrial content in hematopoietic stem and progenitor cells (HSPCs) had been consistently underestimated ([@R7]; [@R3]).

Despite their high preference for glycolysis, mitochondria in HSCs have proven to be not completely inactive. Indeed, the importance of mitochondrial respiration for proliferation and HSC maintenance has been highlighted through studies of ΔΨ~mt~ and by challenges to the electron transport chain ([@R2]; [@R1]; [@R32]). For example, inducible *Succinate Dehydrogenase Complex Subunit D* (*SdhD*)-ESR mutant mice exhibit a conditional *SdhD* gene (encoding a subunit of ETC complex II) mutant, which leads to a decrease in long-term HSCs and committed progenitors of the myeloid lineage ([@R2]). Rieske iron‑sulfur protein (RISP), an essential subunit of ETC complex III, is necessary for maintaining adult HSC quiescence, and its loss by the deletion of *Uqcrfs1* has been shown to lead to the severe pancytopenia ([@R1]).

Additionally, recent studies focused on ΔΨ~mt~ have further emphasized the importance of mitochondrial activity to HSC maintenance. Several research groups have used mitochondrial dyes to demonstrate bone marrow populations are heterogeneous in ΔΨ~mt~ and that long term multi-lineage reconstitution is enriched in low ΔΨ~mt~ fractions ([@R33]; [@R30]). However, we need to pay attention to the activity of xenobiotic efflux pumps, as HSCs exhibit higher pump activity than mature populations, and this causes to the enhanced extrusion of mitochondrial dyes used for measuring ΔΨ~mt~, such as tetramethylrhodamine methyl ester (TMRM) ([@R33]; [@R10]), which in turn can lead to biased results. Indeed, after treatment with Verapamil, an inhibitor of drug efflux pumps, HSPCs have shown higher ΔΨ~mt~ than mature hematopoietic cells ([@R3]).

In this study, while considering the activity of xenobiotic efflux pumps in HSCs, we have assessed the equilibrium between ETC complexes and ATP production in HSPCs to better elucidate the mechanisms sustaining high ΔΨ~mt~ in HSPCs.

2.. Materials and methods {#S2}
=========================

2.1.. Mice {#S3}
----------

C57BL/6 mice were purchased from The Jackson Laboratory. All experiments were approved by the Institutional Animal Care and Use Committee of the Albert Einstein College of Medicine.

2.2.. Mitochondrial membrane potential and superoxide production by flow cytometry {#S4}
----------------------------------------------------------------------------------

Bone marrow cells were isolated and stained for surface markers as previously described ([@R16]). Briefly, bone marrow mononuclear cells (BM-MNCs) were isolated with flushing protocol and were stained to detect different populations by flow cytometry. A mixture of monoclonal antibodies against CD4, CD8, CD3e, B220, TER-119, CD11b, Gr-1, IgM, CD19, CD127, and NK-1.1 was used as a lineage marker (Lineage, or Lin). Multipotent progenitors (MPPs) were identified as Lin^−^ Sca-1^+^c-Kit^+^ (LSK) CD135^--^, and HSCs as LSK CD135^--^CD150^+^CD48^--^. Antibody references are listed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

For mitochondrial membrane potential, cells were incubated with 2 nM TMRM or 1 μM JC-1 (Invitrogen), diluted in StemSPAN SFEM (StemCell Technologies) supplemented with 50 ng/ml SCF (Peprotech), 50 ng/ml TPO (Peprotec) and 50 μM Verapamil or 5 μM Cyclosporin H for 60 min (TMRM) at 37 °C, or 30 min (for JC-1) which is followed by wash.

For mitochondrial superoxide, cells were incubated with 1 μM MitoSOX™ (Thermofisher) diluted in Phosphate-buffered saline (PBS) supplemented with 50 μM Verapamil. MitoSOX™ was incubated 30 min at 37 °C, then washed. Samples were acquired on a LSR II flow cytometer (Becton Dickinson), then data analyzed using FlowJo 12 (TreeStar). For the treatment experiments, 160 nM Rotenone, 1.5 mM TTFA and 40 μM Antimycin A were added for 5 min before recording.

2.3.. Cell sorting {#S5}
------------------

Bone marrow cells were prepared as aforementioned, in addition cells were incubate with Anti-Biotin MicroBeads (10 μl beads per BM, Mylteni Biotech) for 10 min at room temperature, then flow through MACS LS column (Mylteni Biotech) for lineage depletion. Cells were sorted directly into StemSPAN SFEM through a BD FACS ARIA II (Becton Dickinson).

2.4.. Immunofluorenscence {#S6}
-------------------------

Sorted cells were resuspended in 50 μl of StemSPAN (StemCell Technologies) supplemented with 50 ng/ml SCF (Peprotech) and 50 ng/ml TPO (Peprotech) then seeded on Lab-Tek™ II Chamber Slide (Thermo Fisher Scientific) coated with Retronectin (Clonetech). Samples were then immunostained as described previously ([@R3]). Rabbit anti-Ki67 (D3B5, CST, dilution 1:100), rabbit polyclonal anti-TOM20 (FL-145, Santa Cruz, dilution 1:100), mouse monoclonal anti-ATP5A1 (15H4C4, Invitrogen, dilution 1:100), rabbit polyclonal anti-NDUFV1 (Novusbio, dilution 1:100) and mouse monoclonal anti-SDHA (2E3GC12FB2AE2, abcam, dilution 1:100) were used for the detection. *Z*-stack were acquired on a Leica SP5 equipped with 63× oil immersion lens (NA 1.4), pinhole set at 1 airy unit with voxel size 80/200 nm on XY/Z. Stacks were deconvolved using the Richardson-Lucy algorithm ([@R26]) using measured PSF. Representative image renderings were obtained by Imaris 7 (Bitplane).

2.5.. Quantitative colony forming capacity after long-term in vitro culture {#S7}
---------------------------------------------------------------------------

8, 4, 2 and 1 HSCs (LSK CD135^--^CD150^+^CD48^--^) were sorted and cultured as previously reported ([@R15]; [@R29]). For the treatment experiments, 0.45 nM Rotenone, 100 μM TTFA and/or 0.15 μM Antimycin A were added and the medium was changed two time a week for a total of 6 weeks. The frequency of cells with colony forming capacity after long-term *in vitro* culture was calculated using ELDA (extreme limiting dilution analysis) ([@R12]). In each experiment, at least 12 replicates of each dilution were performed, and L-Calc™ Software (StemCell technologies) was used to assess the differences between the two conditions.

2.6.. Quantification and statistical analysis {#S8}
---------------------------------------------

Normality assumption was verified with the D'Agostino-Pearson Omnibus Test. All the groups were filtered for eventual outliers using the ROUT method and tested through one-way ANOVA with Bonferroni correction.

3.. Results {#S9}
===========

3.1.. HSCs show high mitochondrial membrane potential {#S10}
-----------------------------------------------------

Mitochondrial functionality is reflected by ΔΨ~mt~, which thereby represents a key parameter in the study of the HSC metabolism. Since xenobiotic efflux pump activity is higher in HSCs compared to mature cells ([@R10]), the administration of Verapamil, an efflux pump inhibitor, is required for the accurate measurement of ΔΨ~mt~ by TMRM dye ([@R7]; [@R3]). Flow analysis of HSCs (Lin^−^Sca1^+^c-Kit^+^CD135^--^CD150^+^CD48^−^), MPP (Lin^−^Sca1^+^c-Kit^+^CD135^--^), lineage negative (Lin^−^) and positive (Lin^+^) bone marrow populations ([@R22]), stained by TMRM showed a downward trend in ΔΨ~mt~ along with hematopoietic differentiation ([Fig. 1A](#F1){ref-type="fig"}). The administration of Cyclosporine H (CsH), a Ca^2+^-independent multidrug resistance inhibitor ([@R21]) ([Supplementary Fig. 1A](#SD1){ref-type="supplementary-material"}), and the analysis of mitochondrial membrane potential using another ratio-metric dye probe, the dye JC-1 (tetraethylbenzimi-dazolylcarbocyanine iodide) ([Supplementary Fig. 1B](#SD1){ref-type="supplementary-material"}), confirmed that HSCs have the highest ΔΨ~mt~ among bone marrow populations.

To validate high ΔΨ~mt~ as a key feature of HSCs, we measured ki67 positivity to assess whether ΔΨ~mt~ is associated with cell cycle quiescence in HSPCs ([@R25]; [@R35]). MPPs were separated into two fractions, based on their TMRM intensity, specifically, 30% of lowest and highest intensity MPPs (MPP-Lo and MPP-Hi, respectively), and stained for ki67 ([Fig. 1B](#F1){ref-type="fig"}). HSCs and unfractionated MPPs were used as staining controls for quiescent and proliferative populations, respectively. As expected, the percentage of ki67^+^ cells in MPP-Hi was lower than the one in MPP-Lo, and were comparable to HSCs ([Fig. 1C](#F1){ref-type="fig"}, [D](#F1){ref-type="fig"}). Consistently, phenotypic HSCs preferentially reside in the Hi-TMRM fraction (\~43%) ([Fig. 1B](#F1){ref-type="fig"}), with less ki67 positivity ([Fig. 1E](#F1){ref-type="fig"}). These data showed that the quiescent cells were enriched in the MPP-Hi and especially the HSC-Hi fractions, which supports our hypothesis of a close link between ΔΨ~mt~ and the cell cycle state of HSPCs.

3.2.. ETC complex II: complex V ratio is high in HSPCs {#S11}
------------------------------------------------------

ΔΨ~mt~ represents a balance between proton pumping activity in the ETC and the proton flow through F~1~/F~O~ ATP synthase (hereafter referred as complex V). We next assessed mitochondrial ETC complex subunits. Because mitochondrial content changes during differentiation stages (([@R3]) and [Fig. 2A](#F2){ref-type="fig"}), the expression levels of these subunits were analyzed for single mitochondrion. The observed low levels of ATP production in HSCs ([@R7]) indicated that the expression of ATP5A, the fundamental subunit of complex V, was particularly weak in HSPCs and drastically increased following the differentiation process ([Fig. 2B](#F2){ref-type="fig"}).

Complexes I, III and IV, are considered the energy-conserving core of the ETC because they pump protons across the mitochondrial inner membrane ([@R4]). In complex III, the electrons from both complex I and complex II converge, and we therefore analyzed the levels of subunits NADH: Ubiquinone Oxidoreductase Core Subunit V1 (NDUFV1, for complex I) and SDHA (for complex II), respectively. Consistent with previous observations of the metabolic switch during HSC differentiation, the expression of complex I per single mitochondrion increased with hematopoietic maturation: Lin^−^ and Lin^+^ showed significantly higher levels of NDUFV1 than HSCs or MPPs ([Fig. 2C](#F2){ref-type="fig"}). To confirm complex I activity in hematopoietic lineages, we next assessed the incremental change in mitochondrial superoxide production following the addition of a complex I inhibitor, Rotenone. Mitochondrial superoxide basal levels differed among bone marrow populations ([Supplementary Fig. 2A](#SD1){ref-type="supplementary-material"}), and mitochondrial superoxide production as measured by MitoSOX in the presence of Verapamil was calculated as an incremental percentage after drug addition, to normalize each population to its own basal level. As expected, higher increases in mitochondrial superoxide were found in Lin^−^ and Lin^+^ cells ([Fig. 2G](#F2){ref-type="fig"}, left panel).

We next assessed complex II activity by MitoSOX. Accuracy in these measurements requires complex I first be inhibited by Rotenone, to prevent reverse electron transfer to complex I ([@R27]), prior to the additional increment of MitoSOX by TTFA ([Fig. 2G](#F2){ref-type="fig"} and [Supplementary Fig. 2B](#SD1){ref-type="supplementary-material"}). Interestingly, no differences were detected in SDHA expression or complex II activity between HSCs and mature populations ([Fig. 2D](#F2){ref-type="fig"} and [G](#F2){ref-type="fig"}, right panel). The effect of Antimycin A, a complex III inhibitor, on MitoSOX was then investigated ([@R8]). A major increase in mitochondrial superoxide after the addition of Antimycin A was found in Lin^−^, which was consistent with the critical roles played by complex III activity during the hematopoietic differentiation process ([@R1]), but only an incremental increase was observed in the HSC and MPP fractions ([Supplementary Fig. 2C](#SD1){ref-type="supplementary-material"}).

ETC complexes I-IV contributed to an increase in ΔΨ~mt~, but complex V activity uncoupled to dissipate ΔΨ~mt~. We also calculated the respective ratios of complex I and II to complex V ([Fig. 2E](#F2){ref-type="fig"} and [F](#F2){ref-type="fig"}, respectively). Compared to complex I (\~2 times), a significantly higher ratio of complex II/complex V (\~6 times) was found in HSPCs. Collectively, these data support the hypothesis that HSPCs have low ATP production levels, but also have limited ETC coupling capacity, which gives rise to high ΔΨ~mt~.

3.3.. Inhibition of complex II mainly affects ΔΨ~mt~ in HSCs, leading to a reduction of their colony replating capacity in vitro {#S12}
--------------------------------------------------------------------------------------------------------------------------------

In order to deeply investigate the contribution of complex I, II and III to sustaining ΔΨ~mt~, the reduction of TMRM intensity after the administration of their specific inhibitors was analyzed. Consistent with high complex I expression and activity in Lin^−^ cells, the reduction of TMRM intensity by Rotenone was observed in Lin^−^ and Lin^+^ cells ([Fig. 3A](#F3){ref-type="fig"}), suggesting that these populations rely on complex I in contrast to HSPCs. Critically, the greatest reduction (\~40%) of ΔΨ~mt~ by TTFA administration was found in HSCs, which showed significantly larger declines than Lin^−^ and Lin^+^ (\~20%) ([Fig. 3B](#F3){ref-type="fig"}). Antimycin A was used to assess complex III activity. As expected, the addition of Anti-mycin A caused a drop in TMRM intensity (\~45--60%) in all HSCs, MPPs and Lin^−^ cells ([Fig. 3C](#F3){ref-type="fig"}). We went on to perform sequential pharmacological inhibition of complex I, II and III in hematopoietic lineages to determine the contributions of each complex to their respective ΔΨ~mt~. These experiments, together with the highest ratio of complex II: complex I in HSCs, confirmed that complex II was the greatest contributor to sustaining ΔΨ~mt~ in HSCs ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}).

Finally, to investigate the functional importance of each ETC complex in HSPCs, *in vitro* long-term cultures of HSCs were performed in the presence of Rotenone, TTFA and Antimycin A. We first optimized the culture condition with these inhibitors, and confirmed that the low dosage used in our experiments to reduce ΔΨ~mt~ did not induce a significant increase of cell death, as shown by the percentage of DAPI^+^ BM-MNCs after 7 days of *in vitro* culture ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). After 6 weeks of *in vitro* cultures, Rotenone treatment reduced ΔΨ~mt~, but did not show a significant difference in colony formation ([Fig. 3D](#F3){ref-type="fig"}). On the other hand, TTFA caused a reduction in colony-forming capacity ([Fig. 3E](#F3){ref-type="fig"}), and a similar effect was observed for Antimycin A ([Fig. 3F](#F3){ref-type="fig"}). These data highlight the critical role of complex II in the maintenance of HSPCs.

4.. Discussion {#S13}
==============

Mitochondria play a pivotal role in several biological functions, including proliferation, differentiation, and adaptation to stress, due to their ability to produce energy and support biosynthesis ([@R18]). Both ATP production and the TCA cycle rely on ETC. ETC provides the driving force for generating ATP through complex V, while in the TCA cycle complex II catalyzing the reaction that converts succinate to fumarate. The regulation of mitochondrial physiology (e.g. ΔΨ~mt~) is considered one of the key cell-intrinsic biological signals in the process of HSC maintenance ([@R5]).

Our HSC analysis showed that a relatively high number of mitochondria ([@R7]; [@R3]) were inactive in the production of ATP or ROS, but these may still be critical to other as-yet unknown mechanisms which will only be revealed by continued investigation. Recent questions about the high activity of xenobiotic efflux pumps in HSCs have led to the establishment of proper protocols for flow cytometry analysis of ΔΨ~mt~ by TMRM dye. These methods have shown ΔΨ~mt~ is higher in HSPCs than in more mature populations (([@R3]; [@R20]), and [Fig. 1A](#F1){ref-type="fig"}).

This, however, raises several new questions, including how and why ΔΨ~mt~ is sustained at a high level in HSPCs. The balance between proton pumping (by ETC) and proton flow (by complex V) determine ΔΨ~mt~ levels in the cells. In this study, we have demonstrated that the expression levels of complex II relative to complex V are higher in HSPCs than in differentiated cells. Additionally, our data regarding the strong effect of TTFA on ΔΨ~mt~ ([Fig. 3B](#F3){ref-type="fig"}) supports the notion that complex II is a key component responsible for maintaining high ΔΨ~mt~ in HSPCs ([Fig. 2F](#F2){ref-type="fig"}). Although this study examined the roles of complex II under *in vitro* culture conditions, a previous study with *SdhD* mutant mice demonstrated that complex II function was essential for HSC survival and maintenance. SDH (alias complex II) is involved both in ETC and TCA, but it has been challenging to determine its precise role(s) or regulatory pathways in HSCs. Interestingly, fumarate hydratase (Fh1), another enzyme of the TCA cycle which catalyzes the reaction from fumarate to malate, has been proposed as another contributor to the maintenance of adult HSPCs ([@R11]). If this is the case, it would support our idea that the role of complex II in TCA cycle also contributes to HSC maintenance.

5.. Conclusions {#S14}
===============

-   Elucidating the mechanisms that sustain HSC self-renewal is key to our understanding of hematopoietic homeostasis as well as the development of new strategies for HSC transplantation.

-   This study identifies interesting new roles for ETC complex II. Even if complex II does not act as an active proton pump, its activity is fundamental to sustaining high ΔΨ~mt~ and ultimately *in vitro* colony replating capacity. In contrast to complex I, the expression of complex II is not affected by the metabolic switch that occurs during differentiation, which supports the idea that complex II may be involved in other pathways that maintain HSC homeostasis.
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![Mitochondrial membrane potential decrease with differentiation. (A) HSC, MPP, Lin^−^ and Lin^+^ bone marrow fractions were sorted and stained as described in the [Material and Method](#S2){ref-type="sec"} section. TMRM intensity levels in HSCs, MPPs, Lin^−^ and Lin^+^ fraction measured by flow cytometry and normalized on bone marrow mononuclear cells (BM-MNCs)' TMRM intensity. (B) Representative gating strategy for sorting of 30% TMRM lowest (Lo) and 30% TMRM highest (Hi) intensity MPP, and same gating applied to HSC fraction. (C) Representative images and (D) quantification of % of ki67^+^ cells (labeled by grey circles) on total cells (DAPI) in sorted HSC, MPP, MPP-Hi and MPP-Lo fractions. (E) Quantification of ki67^+^ cells as a percentage of total cells in sorted HSC-Hi and HSC-Lo fractions. Error bars represent mean with SD. At least three mice were analyzed per each experiment and the sample size for flow data for each group is shown by dots. ANOVA test (A, D) and *t*-test (E) \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001. n.s. stands for no significant change.](nihms-1051744-f0001){#F1}

![The balance among electron transport chain complexes highlights the role of complex II in HSPCs. (A--F) HSC, MPP, Lin^−^ and Lin^+^ bone marrow fractions were sorted and stained as described in [Material and Method](#S2){ref-type="sec"} section. Representative images and quantification of mitochondrial content in single cell, identified by volume rendering of TOM20 (A). Representative images and quantification of (B) ATP5A, subunit of complex V, (C) NDUFV1, subunit of complex I, (D) SDHA, subunit of complex II, intensity measured for single mitochondria. Ratio of expression levels between complex I and complex V (E) and of complex II and complex V (F) in each bone marrow fraction. (G) Complex I and complex II activity measured by the increment in MitoSOX™ intensity followed by the addition of Rotenone (bottom left) and TTFA (bottom right) detected by flow cytometry in HSC, MPP, Lin^−^ and Lin^+^ bone marrow fractions. Schematic of Rotenone and TTFA administration is also shown (top). Error bars represent mean with SD (A-D, G), or SEM in (E, F). At least three mice were analyzed per each experiment and the sample size for flow data for each group is shown by dots. ANOVA test \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001. n.s. stands for no significant change.](nihms-1051744-f0002){#F2}

![Complex II inhibition, differentially from complex I, causes a drop in ΔΨ~mt~ of HSPC and affects *in vitro* colony replating capacity. (A--C) Quantification of % TMRM decrease after addition of Rotenone, inhibitor of complex I (A), TTFA, inhibitor of complex II (B), and Antimycin A inhibitors of complex III (C) detected by flow cytometry in HSCs, MPPs, Lin^−^ and Lin^+^ cells. (D-F) Limiting dilution assay to measure the frequencies of HSC with colony forming capacity after 6 weeks of *in vitro* culture in presence of Rotenone (D), TTFA (E) and Antimycin A (F) compared to Ctrl condition (the same control was used for the three drugs). The TMRM intensity of live mononuclear cells after 1 week of *in vitro* treatment is also shown (insets). Error bars represent mean with SD. At least three mice were analyzed per each experiment and the sample size for flow data for each group is shown by dots. ANOVA test (A--C) and *t*-test (D--F) \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001.](nihms-1051744-f0003){#F3}
